| Alterations of immune response of non-small cell lung cancer with azacytidine J Wrangle, W Wang, A Koch, H Easwaran, HP Mohammad, F Vendetti, ... Oncotarget 4 (11), 2067, 2013 | 298 | 2013 |
| Deep proteome coverage based on ribosome profiling aids mass spectrometry-based protein and peptide discovery and provides evidence of alternative translation products and near … G Menschaert, W Van Criekinge, T Notelaers, A Koch, J Crappé, ... Molecular & cellular proteomics 12 (7), 1780-1790, 2013 | 166 | 2013 |
| Analysis of DNA methylation in cancer: location revisited A Koch, SC Joosten, Z Feng, TC de Ruijter, MX Draht, V Melotte, ... Nature Reviews Clinical Oncology 15 (7), 459-466, 2018 | 160 | 2018 |
| MEXPRESS: visualizing expression, DNA methylation and clinical TCGA data A Koch, T De Meyer, J Jeschke, W Van Criekinge BMC genomics 16 (1), 1-6, 2015 | 132 | 2015 |
| PROTEOFORMER: deep proteome coverage through ribosome profiling and MS integration J Crappé, E Ndah, A Koch, S Steyaert, D Gawron, S De Keulenaer, ... Nucleic acids research 43 (5), e29-e29, 2015 | 116 | 2015 |
| Biomarkers for detection and prognosis of breast cancer identified by a functional hypermethylome screen J Jeschke, L Van Neste, SC Glöckner, M Dhir, MF Calmon, V Deregowski, ... Epigenetics 7 (7), 701-709, 2012 | 65 | 2012 |
| A proteogenomics approach integrating proteomics and ribosome profiling increases the efficiency of protein identification and enables the discovery of alternative translation … A Koch, D Gawron, S Steyaert, E Ndah, J Crappé, S De Keulenaer, ... Proteomics 14 (23-24), 2688-2698, 2014 | 61 | 2014 |
| DNA methylation–based immune response signature improves patient diagnosis in multiple cancers J Jeschke, M Bizet, C Desmedt, E Calonne, S Dedeurwaerder, S Garaud, ... The Journal of clinical investigation 127 (8), 3090-3102, 2017 | 52 | 2017 |
| MEXPRESS update 2019 A Koch, J Jeschke, W Van Criekinge, M van Engeland, T De Meyer Nucleic acids research 47 (W1), W561-W565, 2019 | 48 | 2019 |
| Epigenetics in renal cell cancer: mechanisms and clinical applications SC Joosten, KM Smits, MJ Aarts, V Melotte, A Koch, VC Tjan-Heijnen, ... Nature Reviews Urology 15 (7), 430-451, 2018 | 47 | 2018 |
| Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review MXG Draht, D Goudkade, A Koch, HI Grabsch, MP Weijenberg, ... Clinical epigenetics 10 (1), 1-16, 2018 | 24 | 2018 |
| Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients T Seremet, A Koch, Y Jansen, M Schreuer, S Wilgenhof, V Del Marmol, ... Journal of translational medicine 14 (1), 1-14, 2016 | 23 | 2016 |
| The role of enteric neurons in the development and progression of colorectal cancer G Rademakers, N Vaes, S Schonkeren, A Koch, KA Sharkey, V Melotte Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1868 (2), 420-434, 2017 | 18 | 2017 |
| Nervous NDRGs: the N-myc downstream–regulated gene family in the central and peripheral nervous system SL Schonkeren, M Massen, R van der Horst, A Koch, N Vaes, V Melotte neurogenetics 20 (4), 173-186, 2019 | 15 | 2019 |
| A combined literature and in silico analysis enlightens the role of the NDRG family in the gut N Vaes, SL Schonkeren, E Brosens, A Koch, CJ McCann, N Thapar, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1862 (10), 2140-2151, 2018 | 9 | 2018 |
| Epigenetic therapy and sensitization of lung cancer to immunotherapy. J Wrangle, W Wang, A Koch, H Easwaran, H Mohammad, P Parsana, ... Cancer Research 73 (8 Supplement), 4619-4619, 2013 | 6 | 2013 |
| The proliferative phase endometrium in IVF/ICSI: an in-cycle molecular analysis predictive of the outcome following fresh embryo transfer S Mackens, S Santos-Ribeiro, A Racca, D Daneels, A Koch, W Essahib, ... Human Reproduction 35 (1), 130-144, 2020 | 1 | 2020 |
| Identification of a predictive signature based on immunohistochemical (IHC), RNA-seq and epigenetic profiling of melanoma metastases for response to ipilimumab-based immunotherapy. T Seremet, A Koch, S Wilgenhof, M Schreuer, Y Jansen, D Lienard, ... Journal of Clinical Oncology 33 (15_suppl), 9052-9052, 2015 | 1 | 2015 |
| Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC G Rademakers, M Massen, A Koch, MX Draht, N Buekers, KAD Wouters, ... Clinical Epigenetics 13 (1), 1-12, 2021 | | 2021 |
| Clinical translation of liquid biopsy DNA methylation biomarkers: Lessons from two systematic reviews K Lommen, Z Feng, CJG Oberije, AJP van de Wetering, S Odeh, A Koch, ... CLINICAL CANCER RESEARCH 26 (11), 67-67, 2020 | | 2020 |
Wim Van CriekingeProfessor Bioinformatics, University of GhentVerified email at ugent.be
